Showing 37 items.
- Gene therapy (links | edit)
- Amikacin (links | edit)
- Monoclonal antibody therapy (links | edit)
- Deferiprone (links | edit)
- Fast track (FDA) (links | edit)
- Alzheimer's disease (links | edit)
- Olaratumab (links | edit)
- Accelerated approval (redirect page) (links | edit)
- Bevacizumab (links | edit)
- Lapatinib (links | edit)
- Transitional cell carcinoma (links | edit)
- Bedaquiline (links | edit)
- Triple-negative breast cancer (links | edit)
- EZH2 (links | edit)
- PARP inhibitor (links | edit)
- Brentuximab vedotin (links | edit)
- Rucaparib (links | edit)
- Glembatumumab vedotin (links | edit)
- Carfilzomib (links | edit)
- Brigatinib (links | edit)
- Bad Pharma (links | edit)
- Food and Drug Administration Safety and Innovation Act (links | edit)
- Pembrolizumab (links | edit)
- Palbociclib (links | edit)
- Copanlisib (links | edit)
- Atezolizumab (links | edit)
- Avelumab (links | edit)
- Venetoclax (links | edit)
- Alectinib (links | edit)
- Umbralisib (links | edit)
- Lecanemab (links | edit)
- Anti-amyloid drugs (links | edit)
- Talk:Pertuzumab (links | edit)
- Talk:Carfilzomib (links | edit)
- Talk:Onyx Pharmaceuticals (links | edit)
- Talk:Empagliflozin (links | edit)
- Talk:Adaptive clinical trial (links | edit)
- Talk:Intercept Pharmaceuticals (links | edit)
- Talk:Phases of clinical research/Archive 1 (links | edit)
- User:Daniel duesentrieb/sandbox (links | edit)
- Antibody–drug conjugate (links | edit)
- Aducanumab (links | edit)
- Amicus Therapeutics (links | edit)
- Breakthrough therapy (links | edit)
- Enfortumab vedotin (links | edit)
- Sacituzumab govitecan (links | edit)
- Osimertinib (links | edit)
- Clovis Oncology (links | edit)
- FDA Accelerated Approval (redirect page) (links | edit)
- Blinatumomab (links | edit)
- Talk:FDA Accelerated Approval (transclusion) (links | edit)
- User talk:Rod57 (links | edit)
- Accelerated Approval (redirect page) (links | edit)
- CDK inhibitor (links | edit)
- Wyeth (links | edit)
- Adaptive design (medicine) (links | edit)
- User:Rli255/sandbox (links | edit)
- Accelerated Approval (FDA) (redirect page) (links | edit)
- Sarepta Therapeutics (links | edit)
- Talk:Accelerated Approval (FDA) (transclusion) (links | edit)
- FDA Accelerated Approval Program (redirect page) (links | edit)
- Migalastat (links | edit)
- Capmatinib (links | edit)
- Loncastuximab tesirine (links | edit)
- Lecanemab (links | edit)
- Tazemetostat (links | edit)
- Selinexor (links | edit)
- Zanubrutinib (links | edit)
- Sotorasib (links | edit)
- Golodirsen (links | edit)
- Trastuzumab deruxtecan (links | edit)
- Brexucabtagene autoleucel (links | edit)
- Eladocagene exuparvovec (links | edit)
- Sparsentan (links | edit)
- Anti-amyloid drugs (links | edit)
- Talk:Accelerated approval (FDA) (transclusion) (links | edit)
- Talk:Alzheimer's disease/Archive 13 (links | edit)
- User:Anaeradze/Evaluate an Article (links | edit)